Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 16 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

12 trials in Phase 3/4

Results Transparency

13%

2 of 16 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 3

11(68.8%)

Phase 2

4(25.0%)

Phase 4

1(6.3%)

16Total

Phase 3(11)

Phase 2(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT01244334Phase 4Completed

Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.

Role: collaborator

NCT00616993Phase 3Completed

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)

Role: lead

NCT00502073Phase 3Completed

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

Role: lead

NCT00548301Phase 3Completed

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

Role: lead

NCT00616070Phase 3Completed

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

Role: lead

NCT00429936Phase 2Completed

Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration

Role: lead

NCT00430092Phase 3Completed

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)

Role: lead

NCT00429923Phase 3Completed

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)

Role: lead

NCT00501579Phase 3Completed

Study of Difluprednate in the Treatment of Uveitis

Role: lead

NCT00549289Phase 3Completed

Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)

Role: lead

NCT00407225Phase 2Completed

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

Role: lead

NCT00406341Phase 3Completed

Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation

Role: lead

NCT00406887Phase 3Completed

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

Role: lead

NCT00407056Phase 3Completed

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

Role: lead

NCT00406497Phase 2Completed

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

Role: lead

NCT00405496Phase 2Completed

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis

Role: lead

All 16 trials loaded